Why the study?
Is the transfemoral ACURATE-neo aortic bioprosthesis safe and effective in high-surgical risk patients with severe symptomatic aortic stenosis?
Is the transfemoral ACURATE-neo aortic bioprosthesis safe and effective in high-surgical risk patients with severe symptomatic aortic stenosis?
The initial North American experience demonstrates that the ACURATE-neo aortic bioprosthesis can be safely and successfully implanted via a transfemoral approach, providing excellent hemodynamic outcomes and a low rate of permanent pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Early North American experience should not change TAVI practice; leaves open comparative safety and durability versus approved devices.
Bagur et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: